Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
Targeting Viral Transcription for HIV Cure Strategies.
Exploring the HIV-1 Rev Recognition Element (RRE)-Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs.
Understanding the neurological implications of acute and long COVID using brain organoids.
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.